Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | HCID 67471061 | HCID 67471061 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86691720 | HCID 86691720 | 36.4% |
Reaction Steps
A suspension of N-((R)-3-chloro-2-hydroxypropyl)-5-((R)-2-(5-fluoro-2-oxo-1,2-dihydropyridin-3-yl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (30 mg, 0.069 mmol) and Cs2CO3 (112 mg, 0.34 mmol) in DMF (0.7 mL) was heated at 85° C. for 1 hour. The reaction mixture was filtered through a GF/F paper and directly purified on reverse phase column chromatography (Biotage SP4 system C-18 12+M column, 0 to 50% acetonitrile/water), to provide the title product as a white solid (10 mg, 36% yield). Unlike Example 6, no erosion of the enantiomeric integrity of the chiral center where HO group resides was observed for this final product. MS (apci) m/z=399.2 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08933084B2 |
|---|
| Source dataset | uspto-grants-2015_01 |
|---|
| ORD ID | ord-e5a2aa48059f4b4fa0e9067514aa6862 |
|---|
| Source note | uspto-grants-2015_01 |
|---|